Our peak young people should be refreshed.
Release time:
2023-05-04
should be refreshed
age: 25 years old
position: peak pharmaceutical production department manufacturing two
entry time: July 2020
"can't stop" position little expert
"new, come here..." this familiar call will float into my ears almost every day, another small partner is asking for reinforcements. The "new" summoned is Ying Zhenxin, which I want to introduce to you.
should be lively and active, belonging to the typical "can't stop" personality, willing to give people a hand wherever they go, and always infect the colleagues around them with their optimism and cheerfulness. I guess it's half born and half should be due to its love of work.
Ying Zhenxin joined Jianfeng Pharmaceutical in July 2020, transferred to the second manufacturing department under construction in November of the same year, and successively participated in the follow-up of the work such as land leveling of the factory, civil construction of the factory, purification and decoration of the workshop, hoisting of production equipment in place, installation and debugging of the equipment, verification and confirmation of the factory facilities and equipment, introduction and trial production of new products... In just three years, he completed the transformation from a young scholar to a small expert in post operation.
While strengthening the training of his own hands-on ability, Ying Zhenxin also fully participated in the drafting and formulation of equipment operation and cleaning SOP, change and risk assessment documents. He is also very eager to learn and likes to ask the bottom line to find out the answers to the doubts. During the commissioning and verification of the equipment, he can always see the picture of him asking the manufacturer's master for learning modestly. He took part in the professional grade examination of pharmaceutical preparation in 2021 and 2022, and obtained the middle and advanced skill certificates with excellent results.
When getting along with colleagues, Ying Zhenxin always adheres to the principle of "help if you can" and never cares how much you pay. I remember once, a batch of stainless steel tables and chairs arrived, and other boys were busy. He and several girls immediately took on the work of loading and unloading all the goods. He asked the girls to carry lighter chairs and other items, and carried tables and shelves by themselves. While sweating profusely, he also reminded his colleagues to pay attention to safety from time to time. During the April 15 epidemic last year, he even volunteered to support production in response to the shortage of production operators due to regional containment.
2022 , Ying Zhenxin was appraised as a "little expert in post operation" in the factory department. However, when it comes to this matter, he is talking about the care and help given to him by the company and his colleagues around him. Just give, don't ask for, always treat the people and things around you with gratitude, this is Ying Zhenxin, a peak youth in the new era. (Ye Ke)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31